Browsing NTNU Open by Author "Eliasson, Björn"
Now showing items 1-5 of 5
-
The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A Scandinavian cohort study
Ueda, Peter; Wintzell, Viktor; Dahlqwist, Elisabeth; Eliasson, Björn; Svensson, Ann-Marie; Franzén, Stefan; Gudbjörnsdottir, Soffia; Hveem, Kristian; Jonasson, Christian; Melbye, Mads; Hviid, Anders; Svanström, Henrik; Pasternak, Björn (Peer reviewed; Journal article, 2021)Aim To assess the comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 (SGLT2) inhibitors versus glucagon-like peptide-1 (GLP-1) receptor agonists in routine clinical practice. Materials ... -
Glucagon-Like Peptide 1 Receptor Agonists and Risk of Diabetic Retinopathy Complications: Cohort Study in Nationwide Registers From Two Countries
Ueda, Peter; Pasternak, Björn; Eliasson, Björn; Svensson, Ann-Marie; Franzén, Stefan; Gudbjörnsdóttir, Soffia; Hveem, Kristian; Jonasson, Christian; Melbye, Mads; Svanström, Henrik (Journal article; Peer reviewed, 2019)Post hoc analyses of the Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (SUSTAIN-6) showed an increased risk of diabetic retinopathy complications associated ... -
Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden
Svanström, Henrik; Ueda, Peter; Melbye, Mads; Eliasson, Björn; Svensson, Ann Mari; Franzen, Stefan; Gudbjörnsdóttir, Soffia; Hveem, Kristian; Jonasson, Christian; Pasternak, Björn (Journal article; Peer reviewed, 2019) -
Use of sodium glucose cotransporter 2 inhibitors and risk of major cardiovascular events and heart failure: Scandinavian register based cohort study
Pasternak, Björn; Ueda, Peter; Eliasson, Björn; Svensson, Ann-Marie; Franzén, Stefan; Gudbjörnsdotttir, Soffia; Hveem, Kristian; Wintzell, Viktor; Melbye, Mads; Svanström, Henrik (Journal article; Peer reviewed, 2019)Objective To investigate the cardiovascular effectiveness of sodium glucose cotransporter 2 (SGLT2) inhibitors in routine clinical practice. Design Cohort study using data from nationwide registers and an active-comparator ... -
Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study
Pasternak, Björn; Wintzell, Viktor; Mellbye, Mads; Eliasson, Björn; Svensson, Ann-Marie; Franzén, Stefan; Gudbjörnsdóttir, Soffia; Hveem, Kristian; Jonasson, Christian; Svanström, Henrik; Ueda, Peter (Peer reviewed; Journal article, 2020)OBJECTIVE To assess the association between use of sodiumglucose co-transporter 2 (SGLT2) inhibitors and risk of serious renal events in data from routine clinical practice. DESIGN Cohort study using an active comparator, ...